By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Epigenomics AG 

Kleine Präsidentenstraße 1

Berlin    D-10178  Germany
Phone: 49-30-24-34-5-0 Fax: +49-30-24-34-55-55



Company News
Epigenomics AG Announces 2016 Second Quarter And Six Months Financial Results And Reports On Operational Highlights 8/10/2016 9:13:56 AM
Epigenomics AG Confidentially Submits Draft Registration Statement For Potential U.S. Public Offering Of ADSs 8/10/2016 9:10:56 AM
Epigenomics AG' Epi proColon Included In Newly Issued USPSTF Guidelines For Colorectal Cancer Screening 6/16/2016 10:28:04 AM
Epigenomics AG Announces 2016 First Quarter Financial Results And Reports On Operational Highlights 5/23/2016 12:47:27 PM
LabCorp (LH) Is First U.S. Laboratory Network To Offer Epigenomics AG’ Epi Pro Colon Colorectal Cancer Screening Test, Nationally Available Immediately 5/9/2016 10:33:58 AM
China FDA Names Epigenomics AG’ Blood-Based Septin9 Colorectal Cancer Test A Most Innovative Medical Product For 2015 5/2/2016 9:03:42 AM
Epigenomics AG Announces Commercial Launch Of Epi proColon In The U.S. 4/27/2016 8:33:45 AM
Epigenomics AG To Present Data On Novel Blood-Based Test For The Detection Of Lung Cancer At AACR Annual Meeting 2016 4/18/2016 9:40:30 AM
Epigenomics AG Receives FDA Approval For Epi proColon 4/13/2016 9:28:17 AM
BioChain Acquires China Rights To Epigenomics AG' Lung Cancer IVD 4/6/2016 10:16:13 AM